Gangwon, South Korea

Woo Ran Lee

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Hugel Inc., Small Lab Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Woo Ran Lee. Retrieved from https://idiyas.com/inventor/woo-ran-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.5

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Woo Ran Lee: Innovator in Microstructure Formulation Techniques

Introduction

Woo Ran Lee is a notable inventor based in Gangwon-do, South Korea. He has made significant contributions to the field of medical technology, particularly in the formulation techniques for botulinum toxin. With a total of 2 patents, his work is poised to enhance the safety and efficacy of medical procedures involving this substance.

Latest Patents

Woo Ran Lee's latest patents focus on microstructure formulation techniques for botulinum toxin. These innovative techniques allow for precise control over the concentration of botulinum toxin, which is crucial for minimizing pain during administration. Furthermore, his inventions enable accurate delivery of the toxin to targeted areas within the human body. This advancement is expected to greatly contribute to the safe and convenient medical use of botulinum toxin.

Career Highlights

Throughout his career, Woo Ran Lee has worked with prominent companies in the industry, including Hugel Inc. and Small Lab Co., Ltd. His experience in these organizations has provided him with valuable insights and expertise in the field of medical innovations.

Collaborations

Some of his notable coworkers include Kyeong Yeop Moon and Chang Jin Lee. Their collaborative efforts have likely played a role in the development of his patented technologies.

Conclusion

Woo Ran Lee's contributions to microstructure formulation techniques for botulinum toxin represent a significant advancement in medical technology. His work not only enhances the safety of procedures but also improves patient comfort.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…